8,700 Studies Reviewed. 87.0% Found Biological Effects. The Evidence is Clear.
Shield Your Body

Note: This study found no significant biological effects under its experimental conditions. We include all studies for scientific completeness.

Immune System

Transcriptional response of primary hippocampal neurons following exposure to 3.0 GHz radiofrequency electromagnetic fields

No Effects Found

Cantu JC, Butterworth JW, Payne JA, Echchgadda I · 2024

Share:

Insufficient information to determine key finding.

Plain English Summary

Summary written for general audiences

This study likely investigated how primary hippocampal neurons respond at the gene expression level when exposed to radiofrequency electromagnetic fields at 3.0 GHz, a frequency commonly used in mobile communications. The research probably measured changes in transcriptional patterns to assess whether RF-EMF exposure triggers alterations in neuronal gene activity.

Cite This Study
Cantu JC, Butterworth JW, Payne JA, Echchgadda I (2024). Transcriptional response of primary hippocampal neurons following exposure to 3.0 GHz radiofrequency electromagnetic fields.
Show BibTeX
@article{cantu_jc_butterworth_jw_payne_ja_echchgadda_i_ce2708,
  author = {Cantu JC and Butterworth JW and Payne JA and Echchgadda I},
  title = {Transcriptional response of primary hippocampal neurons following exposure to 3.0 GHz radiofrequency electromagnetic fields},
  year = {2024},
  doi = {10.1016/s2352-4642(23)00316-4},
  
}
DOI: 10.1016/s2352-4642(23)00316-4

Quick Questions About This Study

This appears to be a database classification error. The study examined anti-inflammatory treatments for pediatric COVID syndrome, not electromagnetic field exposure effects on health.
Researchers tested whether medications like methylprednisolone and tocilizumab could reduce hospital stays for 237 children with COVID-related inflammatory syndrome (PIMS-TS).
Yes, children receiving methylprednisolone had shorter hospital stays (6.9 days) compared to usual care (7.6 days), with 87% probability of benefit.
Tocilizumab showed strong evidence of benefit, reducing hospital stays by 3.3 days compared to usual care (6.6 vs 9.9 days) with >99% probability.
Database errors like this create confusion and reduce trust in EMF research repositories, making it harder to identify legitimate electromagnetic field health studies.